ENTRY       D01898                      Drug
NAME        Haloperidol decanoate (JAN/USP);
            Halomonth (TN)
PRODUCT     HALDOL DECANOATE (Janssen Pharmaceuticals)
  GENERIC   HALOPERIDOL DECANOATE (BluePoint Laboratories)
            HALOPERIDOL DECANOATE (Fresenius Kabi USA)
            HALOPERIDOL DECANOATE (Fresenius Kabi USA)
            HALOPERIDOL DECANOATE (Gland Pharma Limited)
            HALOPERIDOL DECANOATE (Hikma Pharmaceuticals USA)
            HALOPERIDOL DECANOATE (Lifestar Pharma LLC)
            HALOPERIDOL DECANOATE (Meitheal Pharmaceuticals)
            HALOPERIDOL DECANOATE (Mylan Institutional LLC)
            HALOPERIDOL DECANOATE (Patriot Pharmaceuticals LLC)
            HALOPERIDOL DECANOATE (REMEDYREPACK)
            HALOPERIDOL DECANOATE (REMEDYREPACK)
            HALOPERIDOL DECANOATE (REMEDYREPACK)
            HALOPERIDOL DECANOATE (Sagent Pharmaceuticals)
            HALOPERIDOL DECANOATE (Somerset Therapeutics)
            HALOPERIDOL DECANOATE (Zydus Lifesciences Limited)
            HALOPERIDOL DECANOATE (Zydus Pharmaceuticals USA)
FORMULA     C31H41ClFNO3
EXACT_MASS  529.2759
MOL_WEIGHT  530.1135
CLASS       Neuropsychiatric agent
             DG01478  Dopamine antagonist
              DG01474  Dopamine D2-receptor antagonist
             DG03200  Antipsychotic agent
              DG01940  Butyrophenone derivative
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1179
            ATC code: N05AD01
            Chemical structure group: DG00885
            Product (DG00885): D00136<JP/US> D01898<JP/US> D08035<US>
EFFICACY    Antipsychotic, Neuroleptic, Dopamine D2 receptor antagonist
  DISEASE   Schizophrenia [DS:H01649]
COMMENT     Butyrophenone derivative
            Active form of prodrug: Haloperidol [DR:D00136]
TARGET      DRD2 [HSA:1813] [KO:K04145]
  PATHWAY   hsa04080(1813)  Neuroactive ligand-receptor interaction
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07031  Antipsychotics - butyrophenones
            map07213  Dopamine receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AD Butyrophenone derivatives
                 N05AD01 Haloperidol
                  D01898  Haloperidol decanoate (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antipsychotics
              1st Generation/Typical
               Haloperidol
                D01898  Haloperidol decanoate (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1179  Others
                 D01898  Haloperidol decanoate (JAN/USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00885  Haloperidol
                 D01898  Haloperidol decanoate
              DG03200  Antipsychotic agent
               DG01940  Butyrophenone derivative
                DG00885  Haloperidol
                 D01898  Haloperidol decanoate
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00885  Haloperidol
                D01898  Haloperidol decanoate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00885  Haloperidol
                 D01898  Haloperidol decanoate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D01898  Haloperidol decanoate (JAN/USP) &lt;JP/US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01898
            Prodrugs [br08324.html]
             D01898
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01478  Dopamine antagonist
               DG01474  Dopamine D2-receptor antagonist
                DG00885  Haloperidol
              DG03200  Antipsychotic agent
               DG01940  Butyrophenone derivative
                DG00885  Haloperidol
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00885  Haloperidol
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00885  Haloperidol
            Prodrugs [br08324.html(DG00885)]
             DG00885
DBLINKS     CAS: 74050-97-8
            PubChem: 7848960
            ChEBI: 31664
            LigandBox: D01898
            NIKKAJI: J12.121E
ATOM        37
            1   C1b C    16.3100  -17.5700
            2   C1b C    17.5000  -16.8700
            3   C1b C    18.6900  -17.5700
            4   N1y N    19.9500  -16.8700
            5   C1x C    19.9500  -15.4700
            6   C1x C    21.1400  -17.5700
            7   C1x C    21.1400  -14.7700
            8   C1x C    22.3300  -16.8700
            9   C1z C    22.3300  -15.4700
            10  C8y C    23.5900  -14.7700
            11  C8x C    23.5900  -13.4400
            12  C8x C    24.7800  -15.4700
            13  C8x C    24.7800  -12.7400
            14  C8x C    25.9700  -14.8400
            15  C8y C    25.9700  -13.4400
            16  X   Cl   27.1600  -12.7400
            17  C5a C    15.0500  -16.8700
            18  C8y C    13.7900  -17.5700
            19  O5a O    15.0500  -15.4000
            20  C8x C    13.7900  -18.9700
            21  C8x C    12.6000  -19.6700
            22  C8y C    11.3400  -18.9700
            23  C8x C    11.3400  -17.5700
            24  C8x C    12.6000  -16.8700
            25  X   F    10.0800  -19.6700
            26  O7a O    23.5200  -16.1700
            27  C7a C    23.5200  -17.5700
            28  C1b C    24.7100  -18.2700
            29  O6a O    22.2600  -18.2700
            30  C1b C    25.9000  -17.6400
            31  C1b C    27.0900  -18.2700
            32  C1b C    28.2800  -17.6400
            33  C1b C    29.4700  -18.2700
            34  C1b C    30.8000  -17.6400
            35  C1b C    31.9900  -18.2700
            36  C1b C    33.1800  -17.6400
            37  C1a C    34.3700  -18.2700
BOND        39
            1     1  17 1
            2     1   2 1
            3    17  18 1
            4     2   3 1
            5    17  19 2
            6     3   4 1
            7     4   5 1
            8     4   6 1
            9     5   7 1
            10    6   8 1
            11   18  20 1
            12   20  21 2
            13   21  22 1
            14   22  23 2
            15   23  24 1
            16   24  18 2
            17    7   9 1
            18   22  25 1
            19    9  10 1
            20   10  11 1
            21   10  12 2
            22   11  13 2
            23   12  14 1
            24   13  15 1
            25   15  16 1
            26    8   9 1
            27   14  15 2
            28    9  26 1
            29   26  27 1
            30   27  28 1
            31   27  29 2
            32   28  30 1
            33   30  31 1
            34   31  32 1
            35   32  33 1
            36   33  34 1
            37   34  35 1
            38   35  36 1
            39   36  37 1
///
